Joseph Carroll
Comptroller/Controller/Auditor bei RENOVACOR, INC.
Aktive Positionen von Joseph Carroll
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RENOVACOR, INC. | Comptroller/Controller/Auditor | 17.06.2022 | - |
Unternehmenssekretär | 17.06.2022 | - | |
Corporate Officer/Principal | 01.06.2021 | 17.06.2022 |
Karriereverlauf von Joseph Carroll
Ehemalige bekannte Positionen von Joseph Carroll
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Corporate Officer/Principal | 01.06.2017 | 01.06.2021 |
Ausbildung von Joseph Carroll
West Chester University of Pennsylvania | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Corporate Officer/Principal | 2 |
Comptroller/Controller/Auditor | 1 |
Corporate Secretary | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Renovacor, Inc.
Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
- Börse
- Insiders
- Joseph Carroll
- Erfahrung